Stock Screener App

Gratuito -

Installare

20.46

0.05% 0.01

Doximity Inc (DOCS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché DOCS Giù? Forum Previsione

Doximity Inc Borsa (DOCS) Ultime notizie

Doximity (DOCS) CFO discloses 501,549 shares, including 499,722 RSUs, on Form 3 - Stock Titan

Doximity (DOCS) President Steven Zatz receives 55,524 restricted stock units - Stock Titan

Doximity (NYSE: DOCS) president discloses 822 Class A shares - Stock Titan

Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Doximity Inc (DOCS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Doximity Inc (DOCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Doximity Inc (DOCS) Institutional Confidence - TradingKey

Doximity (DOCS) Advances While Market Declines: Some Information for Investors - Yahoo Finance Singapore

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services - DirectorsTalk Interviews

Responsive Playbooks and the DOCS Inflection - Stock Traders Daily

Y Intercept Hong Kong Ltd Invests $9 Million in Doximity, Inc. $DOCS - MarketBeat

Doximity, Inc. $DOCS Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat

Doximity (DOCS) up 11.2% since last earnings report: Can it continue? - MSN

Doximity: Cheaper, But Growth Is Still Missing (NYSE:DOCS) - Seeking Alpha

Is Doximity Struggling After Revenue Miss? - Kalkine Media

Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance Australia

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM) - The Globe and Mail

Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat

DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Inv - GuruFocus

DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire

Doximity interim PAO Sitaram Siddharth sells $49,882 in shares By Investing.com - Investing.com Canada

Doximity interim PAO Sitaram Siddharth sells $49,882 in shares - Investing.com UK

symbol__ Stock Quote Price and Forecast - CNN

Doximity (DOCS) interim PAO trades shares under 10b5-1 plan, exercises options - Stock Titan

AI Margin Pressure And Legal Probe Might Change The Case For Investing In Doximity (DOCS) - simplywall.st

Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN

[144] Doximity, Inc. SEC Filing - Stock Titan

Capital World Investors Has $250.40 Million Holdings in Doximity, Inc. $DOCS - MarketBeat

DOCS (NASDAQ: DOCS) Form 144 reports 2,444-share sale via exercise - Stock Titan

Doximity shares drop 23% after missing revenue targets and AI investment warning - Pluang

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 22.15% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews

Doximity(DOCS) Stock Options Chain | Quotes & News - Moomoo

Law firm investigates Doximity officers for possible shareholder rights breaches - Pluang

BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - Moomoo

DOCS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Shareholders to Learn More About the Investigation | NYSE:DOCS | Press Release - Stockhouse

Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN

Legal & General Group Plc Sells 54,024 Shares of Doximity, Inc. $DOCS - MarketBeat

BNP Paribas Financial Markets Raises Position in Doximity, Inc. $DOCS - MarketBeat

Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review

Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Doximity (NYSE:DOCS) Downgraded by Zacks Research to Strong Sell - MarketBeat

Workday and Doximity shares are soaring, what you need to know - MSN

Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Understanding the Setup: (DOCS) and Scalable Risk - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOC - The National Law Review

Assessing Doximity (DOCS) Valuation After A Year Of Weak Share Price Performance - Yahoo Finance

Bronstein, Gewirtz & Grossman, LLC Is Investigating Doximity, Inc. (DOCS) And Encourages Investors to Connect - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Doximity, Inc. (DOCS) And Encourages Shareholders to Connect - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Doximity, Inc. (DOCS) Stock Analysis: Evaluating The 17.52% Upside Potential For Investors - DirectorsTalk Interviews

DOCS Stock Price, Quote & Chart | DOXIMITY INC-CLASS A (NYSE:DOCS) - ChartMill

Doximity (DOCS) Stock Trends and Sentiment 2026 $DOCS - MarketBeat

Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - AOL.com

WAY

$18.47

1.21%

PINC

$50.10

0.08%

TXG

$34.76

8.17%

PRVA

$23.67

1.11%

HNGE

$69.42

3.55%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters